| Ahmed Abdel-maksoud, MD | |
|
4500 N Campus Ridge Dr, Midland, MI 48640-6123 | |
| (989) 839-6188 | |
| Not Available |
| Full Name | Ahmed Abdel-maksoud |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 4500 N Campus Ridge Dr, Midland, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295917086 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | AA091189 (Michigan) | Primary |
| Entity Name | Indiana University Health Ball Memorial Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235455544 PECOS PAC ID: 9537072640 Enrollment ID: O20031110000505 |
News Archive
Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced its first European symposium, detailing the use of Translational Platforms including Patient-Derived Xenograft (PDX) models in oncology drug discovery and development. The conference will be held on Wednesday 11th February, at the headquarters of One Nucleus in Cambridge, UK and will welcome experts from renowned pharmaceutical companies and prominent academics working in oncology.
Affymetrix, Inc., today announced that it has signed a definitive agreement to acquire eBioscience, Inc., a privately-held San Diego, CA-based company with an industry-leading position in flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics. Under the terms of the agreement, Affymetrix will acquire eBioscience for $330 million in cash subject to certain customary adjustments.
Ever seen or heard something that wasn't there? For most of us such experiences - termed hallucinations - are a normal, fleeting, brain glitch; yet for a few they are persistent, distressing and associated with a range of psychiatric, neurological and eye conditions.
A pre-clinical study led by Virginia Commonwealth University Massey Cancer Center and Department of Internal Medicine researchers suggests that an experimental drug known as dinaciclib could improve the effectiveness of certain multiple myeloma and myeloid leukemia therapies.
Screening for and diagnosing breast cancer is quicker and more precise than ever before thanks to new three-dimensional (3D) mammography being used at the Herman & Walter Samuelson Breast Care Center at Northwest.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ahmed Abdel-maksoud, MD 4401 N Campus Ridge Dr, Midland, MI 48640-6112 Ph: (989) 839-6188 | Ahmed Abdel-maksoud, MD 4500 N Campus Ridge Dr, Midland, MI 48640-6123 Ph: (989) 839-6188 |
News Archive
Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced its first European symposium, detailing the use of Translational Platforms including Patient-Derived Xenograft (PDX) models in oncology drug discovery and development. The conference will be held on Wednesday 11th February, at the headquarters of One Nucleus in Cambridge, UK and will welcome experts from renowned pharmaceutical companies and prominent academics working in oncology.
Affymetrix, Inc., today announced that it has signed a definitive agreement to acquire eBioscience, Inc., a privately-held San Diego, CA-based company with an industry-leading position in flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics. Under the terms of the agreement, Affymetrix will acquire eBioscience for $330 million in cash subject to certain customary adjustments.
Ever seen or heard something that wasn't there? For most of us such experiences - termed hallucinations - are a normal, fleeting, brain glitch; yet for a few they are persistent, distressing and associated with a range of psychiatric, neurological and eye conditions.
A pre-clinical study led by Virginia Commonwealth University Massey Cancer Center and Department of Internal Medicine researchers suggests that an experimental drug known as dinaciclib could improve the effectiveness of certain multiple myeloma and myeloid leukemia therapies.
Screening for and diagnosing breast cancer is quicker and more precise than ever before thanks to new three-dimensional (3D) mammography being used at the Herman & Walter Samuelson Breast Care Center at Northwest.
› Verified 6 days ago
Stephen J Mattichak, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2660 W Sugnet Rd, Midland, MI 48640 Phone: 989-832-0900 Fax: 989-633-0349 | |
Waleed H Doghmi, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 301 W Wackerly St, Midland, MI 48640 Phone: 989-832-0900 Fax: 989-633-0349 | |
Dr. Subramanyam Yadam, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4201 Campus Ridge Drive, Midland, MI 48640 Phone: 989-488-5450 Fax: 989-488-5455 | |
Alan Stuart Josselson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4100 Campus Ridge Dr, Midland, MI 48640 Phone: 989-488-5450 Fax: 989-488-5455 | |
John Blamoun, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4201 Campus Ridge Drive, Midland, MI 48640 Phone: 989-488-5450 Fax: 989-488-5455 | |
Andrzej S. Boguszewski, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 301 W Wackerly St, Midland, MI 48640 Phone: 989-832-0900 | |
Sharon Agnes Levandowski, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4201 Campus Ridge Dr, Midland, MI 48640 Phone: 989-839-6188 Fax: 989-839-6221 |